Reuters UK Business

Italy’s Iveco Group raises 2023 forecasts but burns cash in Q3

By Giulio Piovaccari MILAN (Reuters) -Italian truck and bus maker Iveco Group on Wednesday raised its 2023 guidance for the third time this year but said it burnt cash in the third quarter despite a strong operating-profit result, hitting its shares. The manufacturer said its adjusted earnings before interest and tax (EBIT) from industrial activities …

Italy’s Iveco Group raises 2023 forecasts but burns cash in Q3 Read More »

European shares hit two-week high on healthcare boost; Fed rate verdict eyed

(Reuters) – European shares rose to a near two-week high on Wednesday, boosted by healthcare stocks, with investors gearing up for the U.S. Federal Reserve’s to hold interest rates, as is widely expected, later in the day. The pan-European STOXX 600 was up 0.1% by 0825 GMT, set for its third straight day of gains. …

European shares hit two-week high on healthcare boost; Fed rate verdict eyed Read More »

UK’s Wood Group ropes in Rolls-Royce exec as new CFO

(Reuters) – John Wood Group on Wednesday named Arvind Balan, finance executive at Rolls-Royce, as the British oilfield services and engineering firm’s new chief financial officer, effective April 2024. Balan has been the CFO at the aero-engineer’s Civil Aerospace business for two years and will replace John Wood’s long-term finance boss David Kemp, who announced …

UK’s Wood Group ropes in Rolls-Royce exec as new CFO Read More »

Aston Martin cuts volume target as new sports car hits production snag

(Reuters) -British luxury carmaker Aston Martin posted a bigger than expected quarterly loss on Wednesday and lowered its 2023 volume outlook due to production issues for its new DB12 sports car. Shares in the Gaydon-based company were down more than 7% in early trading. Aston Martin started delivery of its first next-generation sports car, DB12, …

Aston Martin cuts volume target as new sports car hits production snag Read More »

GSK lifts annual forecasts on strong launch of RSV vaccine

By Eva Mathews (Reuters) – GSK on Wednesday raised its full-year profit and sales forecasts for a second time, after better-than-expected quarterly sales of its newly-launched respiratory syncytial virus (RSV) vaccine. The London-listed drugmaker’s shares rose around 3% in early trade. GSK is betting on RSV vaccine Arexvy to be its next blockbuster medicine as …

GSK lifts annual forecasts on strong launch of RSV vaccine Read More »

Portugal’s parliament approves 2024 budget bill on first reading

By Sergio Goncalves LISBON (Reuters) – Portugal’s parliament on Tuesday approved on the first reading the majority Socialist government’s 2024 budget bill, projecting a surplus for the second year in a row and further debt reduction, despite further economic slowdown. Only the 120 Socialist lawmakers backed the bill in the 230-seat house. Except for two …

Portugal’s parliament approves 2024 budget bill on first reading Read More »

Close Bitnami banner
Bitnami